Abstract 1618: Inhibition of lung tumorigenesis by a novel small molecule CA170 targeting the immune checkpoint protein VISTA
Jing Pan(Houston Methodist), Ming You(Medical College of Wisconsin), Charles R. Myers(Medical College of Wisconsin), Achia Khatun(Medical College of Wisconsin), Shizuko Sei(National Cancer Institute), Bryon D. Johnson(Medical College of Wisconsin), Katie Palen(Medical College of Wisconsin), Robert H. Shoemaker(Frederick National Laboratory for Cancer Research), Yao Chen(Nanjing University of Chinese Medicine), Qi Zhang(Jiangnan University), Chuanjia Yang(China Medical University), Yian Wang(Hunan Normal University), Ronald A. Lubet(National Cancer Institute), Li Wang(China Three Gorges University), Weiguo Cui(Medical College of Wisconsin)
Cited by 0
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246
Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
|Cancer Research|2021|220
Tumor Susceptibility of <i>Rassf1a</i> Knockout Mice
|Cancer Research|2005|214